Which has the lower trailing P/E, BIIB or MTD?

MTD has the lower trailing P/E: BIIB trades at 38.92 and MTD at 33.45. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIIB or MTD?

Over the past five years, MTD grew revenue faster — BIIB at a -3.19% CAGR versus MTD at 3.54%.

Is BIIB or MTD more profitable?

MTD runs the higher net margin — BIIB at 8.39% versus MTD at 21.91%.

How have BIIB and MTD total returns compared?

Over the past 10 years, BIIB delivered -3.47% and MTD delivered 13.47% annualized total return. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs Mettler-Toledo International Inc. (MTD)

A side-by-side comparison of Biogen Inc. and Mettler-Toledo International Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

BIIB

Biogen Inc.

$32.49B

$219.88HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

MTD

Mettler-Toledo International Inc.

$30.03B

$1,486.19HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — BIIB vs MTD

growth of $100 · dividends reinvested · last 10y

BIIB -28.1% (-3.2%/yr)MTD +256.7% (+13.6%/yr)MTD compounded faster over this window

BIIB MTD

BIIB vs MTD: by the numbers

•BIIB is the larger company ($32.49B vs $30.03B market cap).
•MTD trades at the lower trailing earnings multiple (33.45 vs 38.92 P/E), one valuation lens rather than an overall verdict.
•MTD converts more revenue to profit (21.91% vs 8.39% net margin).
•MTD grew revenue faster over the past five years (3.54% vs -3.19% CAGR).

Metrics side by side

Valuation

Metric	BIIB	MTD
P/E ratio	38.92	33.45
Forward P/E	17.71	31.40
PEG ratio	N/A	3.03
P/S ratio	3.27	7.26
P/B ratio	1.72	2342.07
EV / EBITDA	N/A	24.59
FCF yield	8.30%	2.88%

Profitability

Metric	BIIB	MTD
Gross margin	67.71%	58.35%
Operating margin	12.79%	28.41%
Net margin	8.39%	21.91%
ROE	4.43%	7062.40%
ROIC	4.28%	38.19%

Growth (annualized)

Metric	BIIB	MTD
Revenue CAGR (5Y)	-3.19%	3.54%
EPS CAGR (5Y)	-18.67%	10.81%
FCF CAGR (5Y)	-11.63%	2.13%
Total return CAGR (5Y)	-4.98%	1.35%

Frequently asked

Which has the lower trailing P/E, BIIB or MTD?: MTD has the lower trailing P/E: BIIB trades at 38.92 and MTD at 33.45. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIIB or MTD?: Over the past five years, MTD grew revenue faster — BIIB at a -3.19% CAGR versus MTD at 3.54%.
Is BIIB or MTD more profitable?: MTD runs the higher net margin — BIIB at 8.39% versus MTD at 21.91%.
How have BIIB and MTD total returns compared?: Over the past 10 years, BIIB delivered -3.47% and MTD delivered 13.47% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full MTD analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio Mettler-Toledo International P/E ratio Biogen ROE Mettler-Toledo International ROE Biogen operating margin Mettler-Toledo International operating margin Biogen revenue growth Mettler-Toledo International revenue growth Biogen free cash flow Mettler-Toledo International free cash flow

Biogen & Mettler-Toledo International appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.